Despite the different mechanisms underlying cancer resistance to EGFR-TKIs and chemotherapy, these findings are in agreement with a recent report that miR-26a is among the key non-coding RNAs that mediate lung cancer resistance to cisplatin [55]. The gene discussed is EGFR; the disease is lung carcinoma.